MDxHealth (MDXH) Cash from Financing Activities (2021 - 2026)

MDxHealth has disclosed Cash from Financing Activities across 5 years of filings, most recently posting $16.1 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $16.1 million, down 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.5 million (up 0.71% YoY), and the FY2025 annual result was $3.0 million, down 93.35% from the prior year.
• Cash from Financing Activities came in at $16.1 million for Q1 2026 at MDxHealth, up from $8.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $33.6 million in Q3 2024 to a low of -$814000.0 in Q1 2022.
• The 4-year median for Cash from Financing Activities is $9.0 million (2025), against an average of $11.0 million.
• Across the five-year window, Cash from Financing Activities plunged 75.81% in 2025 and decreased 25.0% in 2026, its largest moves.
• MDxHealth's Cash from Financing Activities stood at -$799000.0 in 2022, then jumped by 210.64% to $884000.0 in 2024, then surged by 818.33% to $8.1 million in 2025, then soared by 98.51% to $16.1 million in 2026.
• The last three Cash from Financing Activities figures came in at $16.1 million (Q1 2026), $8.1 million (Q3 2025), and $9.8 million (Q2 2025), per Business Quant data.